Chemicals block ability of flu virus to replicate in cells; goal is to develop medicines that fight much-feared pandemic influenza outbreaks
A new way to attack flu viruses is taking shape in laboratories at Rutgers University, where scientists have identified chemical agents that block the virus’s ability to replicate itself in cell culture.
These novel compounds show promise for a new class of antiviral medicines to fight much-feared pandemic influenzas such as the looming “bird flu” threats caused by the H5N1 influenza A virus and the new H7N9 virus responsible for a 2013 outbreak in China.
Timely production of a vaccine is difficult when a pandemic flu strikes. A viable alternative is to treat with drugs.
“Right now there’s really only one effective oral drug for treating influenza,” said Eddy Arnold, Board of Governors Professor of chemistry and chemical biology in the School of Arts and Sciences at Rutgers and a member of the Center for Advanced Biotechnology and Medicine. And just as bacteria develop resistance to antibiotics, Arnold notes that some flu strains have developed resistance to Tamiflu, the sole orally available anti-flu drug.
Arnold and his collaborators have been working to create drugs beyond Tamiflu, especially ones that target different parts of the virus, using an approach that helped in the development of powerful anti-AIDS drugs. By synthesizing chemical compounds that bind to metal ions in a viral enzyme, the researchers found they could halt that enzyme’s ability to activate a key step in the virus’s replication process.
In Arnold’s words, his team’s compounds “really gum up” the targeted enzyme of influenza virus.
“We’re at a key proof of principle stage right now,” he said. “It’s not trivial to go from this point to actually delivering a drug, but we’re optimistic – this class of inhibitors has all the right characteristics.”
Rutgers’ search for these binding compounds relies on technology that reveals the structure of this enzyme in extremely fine detail. Researchers Joseph Bauman and Kalyan Das first produced high-resolution images of an H1N1 flu enzyme, and Bauman and postdoctoral researcher Disha Patel screened 800 small molecule fragments for binding.
The researchers in Arnold’s lab worked with Edmond LaVoie, professor and chair of medicinal chemistry in the Ernest Mario School of Pharmacy, to modify those compounds, making them more potent and selective in blocking the flu enzyme’s activity. Working with virologist Luis Martinez-Sobrido at the University of Rochester, they were able to detect antiviral activity of the compounds in cells.
The Latest on: Anti-Flu Medicines
- President Trump wants you to get your flu shoton November 10, 2019 at 9:00 pm
Its onset this year was early and there was a higher than average number of cases. The U.S. should prepare for a robust flu season, starting this month. Anti-flu prescription medicines such as Tamiflu ...
- A New Anti-Flu Weapon for People at High Risk of Complicationson November 7, 2019 at 5:13 am
Also, Tamiflu is available in a liquid, which might be easier for people who have trouble swallowing pills. There are side effects associated with both drugs, although most people won’t experience ...
- EU to share anti-flu drugson November 5, 2019 at 9:18 pm
At an emergency meeting in Luxembourg yesterday, ministers said that they would share their stockpiles of anti-flu drugs and co-operate on research to develop a vaccine specifically for swine flu.
- Rutgers Scientists Discover Molecules that Show Promise for New Anti-Flu Medicineson October 3, 2019 at 5:00 pm
And just as bacteria develop resistance to antibiotics, Arnold notes that some flu strains have developed resistance to Tamiflu, the sole orally available anti-flu drug. Arnold and his collaborators ...
- Computer-based research could pave way for anti-flu drugs of the futureon September 23, 2019 at 5:28 am
From the 1,700 approved drugs tested, researchers identified an anabolic steroid used in menopausal hormone therapy as a starting point for new anti-flu drugs. The findings could be used in lab-based ...
- COA recommends probe of ex-GSIS chief Garcia, 9 otherson August 3, 2019 at 5:00 am
president Winston Garcia and nine other former officials of the state-pension agency in connection with the alleged anomalous procurement of anti-flu drugs in 2006 amounting to P25.132 million. In a ...
- Georgian PM: All citizens will receive anti-flu drug Tamiflu free or chargeon January 11, 2019 at 9:21 am
Georgian Prime Minister Mamuka Bakhtadze has stated that the state will cover the expenses for anti-flu medicine Tamiflu and Georgian citizens in need of the medicine will receive it free of charge, ...
- Meagre ranks of anti-flu drugs look set to growon September 4, 2018 at 5:00 pm
Large-scale trials of a new compound show that it quickly beats back the influenza virus — results that could admit this compound to the small club of effective antiviral flu drugs. For the 2017–18 ...
- Anti-flu drug exploits weakness in H3N2 strainon March 19, 2018 at 8:47 am
The UCSD researchers had previously developed small-molecule anti-flu drugs that could bind to one manganese atom, Cohen explained during the ACS conference. The team realized that “even just a small ...
- EQS-News: Shineway worked overtime throughout the Chinese New Year holiday to produce anti-flu medicationson February 26, 2018 at 3:54 am
For Immediate Release*? ????? *China Shineway Pharmaceutical Group Limited *(*Stock Code: 2877*) *Shineway worked overtime throughout the Chinese New Year holiday to produce anti-flu medications* ...
via Google News and Bing News